Manager, Financial Planning & Analysis
IDEAYA Biosciences
Summary
IDEAYA is seeking a Financial Planning and Analysis Manager to join the Finance team. The Financial Planning & Analysis Manager will be a finance business partner between Finance and the Clinical Operations team focusing on budgeting, forecasting and financial close for clinical trials in IDEAYA's robust and growing pipeline. The ideal candidate will be detail-oriented, show an initiative to learn, embrace a collaborative approach, and thrive in a dynamic, fast-paced environment. This position is based in our South San Francisco headquarter offices and required to be onsite four days per week.
Job description
What you'll do
- Support the development of enterprise-level financial planning, including an annual multiyear budget, semi-annual forecast, and strategic initiatives, incorporating sensitivity and risk analysis and generating departmental budgets and targets for the organization
- Clinical Trials budgeting, forecasting, and reporting processes
- Monthly close activities including preparing clinical trial accruals
- Clinical Trials Metrics Forecast Reporting
- Monthly and quarterly financial performance reporting and communications, including variance analysis to functional leaders, company management, and the Board of Directors
- Establish and maintain relationships with key internal and external stakeholders such as clinical team, program management team and external CROs and become trusted finance partner across the organization
- Leverage the Company's FP&A tool and ongoing support
- Review and analyze internal financial data to identify issues, opportunities, and trends to provide business owners and senior leaders with financial analysis input to drive decision-making
- Understand and maintain Sarbanes-Oxley (SOX) documentation and requirements for assigned area
- Assist with ad hoc tasks as assigned and perform other duties as directed
Requirements
- Bachelor's degree in Accounting or Finance; MBA or CPA preferred
- 4-7 years of related experience with success in a growth company or public accounting
- Strong understanding of accounting and financial reporting
- Demonstrated ability to consistently work within fixed timeframes and meet deadlines
- Strong analytical and financial modeling skills with the ability to quickly grasp and apply analytical concepts
- Solid understanding of US GAAP accounting and finance, including preparing financial statements and forecasts
- Proactive communicator with excellent verbal and written skills
- Must be capable of building solid relationships with colleagues
- Maintain the highest standards of accuracy and precision; detail-oriented, highly organized, and resourceful
- Must possess an exceptional work ethic, team mentality, positive attitude, highly driven, self-motivated, and excellent business partnering skills
- Passion for technology and genuine desire to make meaningful contributions on a team with big aspirations
- Proficiency in Excel and PowerPoint is required
- Experience in the biotech/pharmaceutical industry experience a plus
- Big 4 experience with a focus in the Life Science industry is a plus
Benefits
- Medical, Dental & Vision
- 401(k)
- ESPP
- Wellness Programs
- Short-Term Incentive Plan
- Stock Option Awards
Company overview
IDEAYA Biosciences is a clinical-stage precision medicine oncology company headquartered in South San Francisco, California. Founded in 2015, the company is dedicated to the discovery, development, and commercialization of transformative therapies for cancer patients. IDEAYA's innovative approach integrates expertise in small-molecule drug discovery, structural biology, and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers. The company focuses on developing tailored, potentially first-in-class targeted therapies aligned with the genetic drivers of disease, with a primary emphasis on synthetic lethality – an emerging class of precision medicine targets. IDEAYA has built a deep pipeline of product candidates focused on synthetic lethality and antibody-drug conjugates (ADCs) for molecularly defined solid tumor indications. The company's mission is to bring forth the next wave of precision oncology therapies that are more selective, more effective, and deeply personalized, with the goal of altering the course of disease and improving clinical outcomes for cancer patients. IDEAYA went public on NASDAQ in May 2019 (NASDAQ: IDYA) and has established strategic collaborations with major pharmaceutical companies including Pfizer, Gilead Sciences, and GlaxoSmithKline.